Replies to post #38 on Ambrx Biopharma Inc (AMAM)

[MT101]

57% success rates during trial phase is huge! This is potentially the official cure for breast cancer. Thought I’d never see this in my lifetime. Truly incredible. This stock should be $100+. Curing breast cancer is priceless. Cheers to all that held their shares!

[Hercules1]

$AMAM:

100% disease control is simply massive.

we are looking at a $50 dollar stock here.


1 year price target is $50 to $60.